Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
American Journal of Diseases of Children (1960)
|
November 1, 1976
Malignant peritoneal mesothelioma in a child
S I Gutman, P G Steinherz, G F Gray
American Clinical Laboratory
|
December 9, 1995
The FDA's perspective on clinical laboratory devices. The premarket review and evaluation process
K J Aziz, C A Sliva, S I Gutman
Journal of Toxicology and Environmental Health
|
April 1, 1991
Comparison of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated hepatotoxicity in C57BL/6J and DBA/2J mice
E S Shen, S I Gutman, J R Olson
American Journal of Clinical Pathology
|
April 1, 1988
The use of laboratory intervention to stem the flow of fresh-frozen plasma
R R Solomon, J S Clifford, S I Gutman
Diabetes Technology & Therapeutics
|
February 3, 2005
Consumers report glucose meter problems to FDA
Steven I Gutman, Janie G Fuller, Ethan D Hausman
The American Journal of Medicine
|
June 1, 1976
Methyldopa Hepatitis. A report of six cases and review of the literature
J S Rodman, D J Deutsch, S I Gutman
Acta Endocrinologica
|
November 1, 1992
Malignant prolactinoma
M Berezin, I Gutman, R Tadmor, et al.
Expert Review of Molecular Diagnostics
|
September 10, 2005
FDA perspectives on pharmacogenetic testing
Courtney C Harper, Reena Philip, Max Robinowitz, et al.
Human Genomics
|
February 8, 2006
FDA perspectives on potential microarray-based clinical diagnostics
Zivana Tezak, Daya Ranamukhaarachchi, Estelle Russek-Cohen, et al.
Neurosurgery
|
February 1, 1987
Visual hallucinations associated with pituitary adenoma
Z Ram, G Findler, I Gutman, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
American Journal of Diseases of Children (1960)
|
November 1, 1976
Malignant peritoneal mesothelioma in a child
S I Gutman, P G Steinherz, G F Gray
American Clinical Laboratory
|
December 9, 1995
The FDA's perspective on clinical laboratory devices. The premarket review and evaluation process
K J Aziz, C A Sliva, S I Gutman
Journal of Toxicology and Environmental Health
|
April 1, 1991
Comparison of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated hepatotoxicity in C57BL/6J and DBA/2J mice
E S Shen, S I Gutman, J R Olson
American Journal of Clinical Pathology
|
April 1, 1988
The use of laboratory intervention to stem the flow of fresh-frozen plasma
R R Solomon, J S Clifford, S I Gutman
Diabetes Technology & Therapeutics
|
February 3, 2005
Consumers report glucose meter problems to FDA
Steven I Gutman, Janie G Fuller, Ethan D Hausman
The American Journal of Medicine
|
June 1, 1976
Methyldopa Hepatitis. A report of six cases and review of the literature
J S Rodman, D J Deutsch, S I Gutman
Acta Endocrinologica
|
November 1, 1992
Malignant prolactinoma
M Berezin, I Gutman, R Tadmor, et al.
Expert Review of Molecular Diagnostics
|
September 10, 2005
FDA perspectives on pharmacogenetic testing
Courtney C Harper, Reena Philip, Max Robinowitz, et al.
Human Genomics
|
February 8, 2006
FDA perspectives on potential microarray-based clinical diagnostics
Zivana Tezak, Daya Ranamukhaarachchi, Estelle Russek-Cohen, et al.
Neurosurgery
|
February 1, 1987
Visual hallucinations associated with pituitary adenoma
Z Ram, G Findler, I Gutman, et al.
Page
of 6